Andon Health Co., Ltd. (SHE:002432)
China flag China · Delayed Price · Currency is CNY
54.10
+0.92 (1.73%)
Nov 17, 2026, 3:04 PM CST

Andon Health Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
1,0921,3562,5783,17226,2652,340
Other Revenue
9.859.8513.8558.6650.5157.06
1,1021,3662,5923,23126,3152,397
Revenue Growth
-29.80%-47.32%-19.77%-87.72%997.80%19.36%
Cost of Revenue
440.76523.38784.961,2755,529884.82
Gross Profit
661.04842.211,8071,95620,7861,512
Selling, General & Admin
663.71845.71863.38886.052,004496.55
Research & Development
283.01323.57260.69278.46264.8966.73
Other Operating Expenses
-2.45-0.023.441.64.156.25
Operating Expenses
940.31,1661,1301,2032,286592.96
Operating Income
-279.26-324.28677.15752.6618,500919.31
Interest Expense
-140.01-113.52-67.16-12.43-4.75-13.3
Interest & Investment Income
426.91857.48800.45735.36274.162.35
Currency Exchange Gain (Loss)
10.3410.34-11.9240.1335.26-2.2
Other Non Operating Income (Expenses)
-170.98-4.09-2.26-2.8-1.98-3.86
EBT Excluding Unusual Items
-153425.921,3961,51318,803962.29
Impairment of Goodwill
----89.5-125.26-
Gain (Loss) on Sale of Investments
7,1542,114735.6309.29-326.430.49
Gain (Loss) on Sale of Assets
-1.1-0.010.67-0.5-6.430.01
Asset Writedown
-0.67-5.32-25.45-153.14-46.95-1.88
Other Unusual Items
-11.76-6.87-0.21.28-39.858.72
Pretax Income
6,9872,5272,1071,58018,258999.63
Income Tax Expense
1,096257.75306.83231.111,77465.23
Earnings From Continuing Operations
5,8912,2701,8001,34916,484934.4
Minority Interest in Earnings
-8.24-2.76-131.31-97.62-453.93-25.76
Net Income
5,8832,2671,6691,25216,030908.64
Net Income to Common
5,8832,2671,6691,25216,030908.64
Net Income Growth
211.41%35.84%33.33%-92.19%1664.19%274.96%
Shares Outstanding (Basic)
422433438445456455
Shares Outstanding (Diluted)
423435441452467455
Shares Change
-4.40%-1.38%-2.49%-3.23%2.82%5.02%
EPS (Basic)
13.945.233.812.8135.142.00
EPS (Diluted)
13.925.213.782.7734.302.00
EPS Growth
225.74%37.73%36.73%-91.93%1615.80%257.03%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
-434.39-431.13912.831,55718,010222.67
Free Cash Flow Per Share
-1.03-0.992.073.4438.530.49
Dividend Per Share
1.6501.6500.2000.3002.5000.700
Dividend Growth
725.00%725.00%-33.33%-88.00%257.14%1066.67%
Gross Margin
60.00%61.67%69.72%60.54%78.99%63.09%
Operating Margin
-25.35%-23.75%26.12%23.29%70.30%38.35%
Profit Margin
533.95%165.99%64.38%38.74%60.92%37.91%
Free Cash Flow Margin
-39.43%-31.57%35.22%48.20%68.44%9.29%
EBITDA
-272.36-297.33730.86829.0818,574985.28
EBITDA Margin
-24.72%-21.77%28.19%25.66%70.58%41.10%
D&A For EBITDA
6.8926.9653.7176.4274.1865.97
EBIT
-279.26-324.28677.15752.6618,500919.31
EBIT Margin
-25.35%-23.75%26.12%23.29%70.30%38.35%
Effective Tax Rate
15.68%10.20%14.56%14.62%9.71%6.53%
Revenue as Reported
1,1021,3662,5923,23126,3152,397
Advertising Expenses
-85.82108.8282.7770.3851.22